Cell Point India last traded at ₹15.45 (2026-10-13). Over the past month the stock moved +3.3%, three months the stock moved -15.6%, year the stock moved -18.0%. Its closing range over 52 weeks is ₹12.75 – ₹18.65, with the latest close 17.2% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2001, Cell Point (India) Ltd trades in smartphones and other consumer durable electronic goods[1]
Business Overview:[1][2] a) CPIL is in the business of mobile retailing. It offers mobile handsets, mobile accessories, and mobile related products through it retail chains. Company does multi— brand retail selling of Smartphones and allied accessories from manufacturers like Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Redmi, and Oneplus. b) It is also in multi brand retail selling of consumer durable electronics good like Smart TVs, LED TVs, LCD TVs, Air Conditioners, etc. from brands like Xiaomi, Redmi, Voltas, LG, Acer, etc. c) Presently, company is operating 80 stores across Andhra Pradesh.
In the latest quarter (Mar 2026), Cell Point India reported sales of ₹191.00 crore (+17.2%) and net profit of ₹0.00 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 191.00 | 6.00 | 3.10 | 0.00 | -0.07 |
| Sep 2025 | 177.00 | 4.00 | 2.40 | 0.00 | 0.10 |
| Mar 2025 | 171.00 | 3.00 | 1.60 | 2.00 | 1.09 |
| Sep 2024 | 154.00 | 5.00 | 3.00 | 0.00 | 0.12 |
| Mar 2024 | 163.00 | 4.00 | 2.50 | 0.00 | 0.01 |
| Sep 2023 | 158.00 | 5.00 | 2.90 | 2.00 | 0.90 |
| Mar 2023 | 147.00 | 9.00 | 6.00 | 3.00 | 2.07 |
| Sep 2022 | 149.00 | 9.00 | 6.00 | 4.00 | 34.28 |
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +3.4% | +16.3% | +12.0% | +17.2% |
| Operating profit growth | -44.4% | -66.7% | -20.0% | +50.0% |
| Net profit growth | -100.0% | -33.3% | -100.0% | – |
| EPS growth | -99.6% | -47.3% | -88.9% | -800.0% |
| OPM % | 3.0% | 1.6% | 2.4% | 3.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Cell Point India reported sales of ₹368.00 crore (+13.2%) and net profit of ₹0.00 crore (-100.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 368.00 | 10.00 | 3.00 | 0.00 | 0.03 |
| Mar 2025 | 325.00 | 7.00 | 2.00 | 2.00 | 1.21 |
| Mar 2024 | 310.00 | 9.00 | 3.00 | 2.00 | 0.90 |
| Mar 2023 | 286.00 | 18.00 | 6.00 | 7.00 | 4.93 |
| Mar 2022 | 260.00 | 11.00 | 4.00 | 2.00 | 14.50 |
| Mar 2021 | 219.00 | 8.00 | 4.00 | 1.00 | 6.07 |
| Mar 2020 | 270.00 | 9.00 | 4.00 | 2.00 | 14.06 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | -18.9% | +18.7% | +10.0% | +8.4% | +4.8% | +13.2% |
| Operating profit growth | -11.1% | +37.5% | +63.6% | -50.0% | -22.2% | +42.9% |
| Net profit growth | -50.0% | +100.0% | +250.0% | -71.4% | +0.0% | -100.0% |
| EPS growth | -56.8% | +138.9% | -66.0% | -81.7% | +34.4% | -97.5% |
| OPM % | 4.0% | 4.0% | 6.0% | 3.0% | 2.0% | 3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Cell Point India.
Get Free AI Stock Analysis FREE →No recent news available for Cell Point India.
Cell Point India shares were last quoted at ₹15.45 (-0.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Cell Point India has a price-to-earnings (P/E) ratio of 465.00 and a price-to-book (P/B) ratio of 0.35. The industry P/E is 29.63.
The 52-week high of Cell Point India is ₹21.10 and the 52-week low is ₹11.70.
The market capitalisation of Cell Point India is about ₹26.07 crore.
In the latest quarter (Mar 2026), Cell Point India reported sales of ₹191.00 crore (+17.2%) and net profit of ₹0.00 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Cell Point India has a 3-year ROE of 1.00%, 3-year profit growth of -79.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 73.06% of Cell Point India.
Cell Point India belongs to the Speciality Retailers sector.